BioSpace News Archive

Jaya Biosciences, Inc. presented promising non-clinical data for a novel treatment approach in Alzheimer’s disease at the 23rd Annual Needham Virtual Healthcare Conference.

NeuroCatch Inc., a leading medical device company that enables rapid access to an objective assessment of brain health at the point of care, announced the release of PeakSelect, an innovative software tool designed to improve clinical decision making.

Tome Biosciences, Inc. today announces the issuance of US Patent 11,952,571 for “Systems, Methods, and Compositions for Site-Specific Genetic Engineering Using Programmable Addition via Site-Specific Targeting Elements (PASTE)” by the US Patent and Trademark Office.

Denovo Biopharma LLC today announced positive results for its biomarker‑guided Phase 2b clinical trial (ENLIGHTEN) designed to assess the efficacy and safety of DB104 (liafensine) in patients with treatment-resistant depression (TRD).

GE HealthCare, a leader in precision care innovation, will announce its first quarter 2024 financial results before the market opens on Tuesday, April 30, 2024.

Xencor, Inc. today announced the appointment of Bart Cornelissen to senior vice president and chief financial officer.

HeartBeam, Inc. (NASDAQ: BEAT) today announced new data demonstrating that applying the company’s artificial intelligence (AI) algorithms to vectorcardiography (VCG) showed considerably improved performance in the detection of atrial flutter over single-lead electrocardiograms (ECGs) and similar performance to 12-lead ECGs, the standard for diagnosing atrial flutter.

EFISHient Protein, a leading Israeli FoodTech company, proudly announces the successful completion of the Tilapia cell line development.